FDA OKs New Next-Gen Pill for Rare Lung Cancer - WebMD
Jun 11, 2025 · The FDA has approved an oral pill called taletrectinib (Ibtrozi) to treat people who have a rare type of non-small-cell lung cancer (NSCLC) that is linked to a faulty ROS1 gene …
U.S. FDA Approves EMRELIS™ (telisotuzumab vedotin-tllv) for …
May 14, 2025 · In December 2021, the FDA granted EMRELIS Breakthrough Therapy Designation (BTD) based on Phase 2 LUMINOSITY study data. EMRELIS is being further …
Expanding targeted therapy for lung cancer - Nature
Dec 10, 2025 · Targeted therapies continue to transform the landscape of non-small-cell lung cancer (NSCLC). In 2025, the US Food and Drug Administration approved two targeted …
Biomarker Therapy in 2025: More Lung Cancer Options, Competition in New ...
Dec 18, 2025 · NEW YORK – A wave of biomarker-targeted therapies entered the market in 2025, providing new options to lung cancer patients and increasing competition in novel drug …
Clinical Trials Highlight New Treatment Approaches for Lung …
May 16, 2025 · Enter aumolertinib, an EGFR-targeted therapy approved in China for the first-line treatment of patients with locally advanced or metastatic NSCLC that harbors an exon 19 …
FDA Approves New Targeted Therapy for Advanced Lung Cancer
Aug 14, 2025 · On August 8, the Food and Drug Administration (FDA) granted accelerated approval of Hernexeos (zongertinib), a new targeted therapy for previously treated people with …
Targeted Drug Therapy for Non-small Cell Lung Cancer
Learn about targeted drugs for non-small cell lung cancer, which work differently than chemotherapy and tend to have different side effects.
Zongertinib in Previously Treated HER2-Mutant Non–Small-Cell Lung Cancer
Apr 28, 2025 · Innovative oral targeted therapies are warranted for patients with human epidermal growth factor receptor 2 (HER2)–mutant non–small-cell lung cancer (NSCLC).
Emerging Targeted Therapies in Non-Small-Cell Lung Cancer (NSCLC)
Jan 22, 2025 · Abstract Targeted therapies have changed the treatment landscape of non-small-cell lung cancer and led to improved patient survival across all stages of lung cancer. Newer …
Frontiers | Targeted therapy of non-small cell lung cancer: …
Sep 26, 2024 · Lung cancer is a leading cause of cancer-related deaths globally, and traditional chemotherapy has limited efficacy in treating advanced non-small cell lung cancer (NSCLC). …